Prognostic value of 99mTc-HYNIC Annexin-V imaging in squamous cell carcinoma of the head and neck

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 1, 2008, Pages 47-52

  Loose, David ^a   Vermeersch, Hubert ^a   De Vos, Filip ^a   Deron, Philippe ^a   Slegers, Guido ^a   Van De Wiele, Christophe ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Annexin V; Apoptosis imaging; Molecular imaging; Oncology; Prognosis

Indexed keywords

HYDRAZINONICOTINAMIDE TC 99M; LIPOCORTIN 5; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M HYNIC ANNEXIN V;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; IMAGE RECONSTRUCTION; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS; HEAD AND NECK TUMOR; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; ANNEXIN A5; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 36849010988     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0577-0     Document Type: Article

References (21)

1. Parkin D, Läärä E, Muir C. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988;41:184-97.
2. Chin D, Boyle G, Porceddu S, Theik D, Parsons P, Coman W. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 2006;6:1111-8.
3. Stoll C, Baretton G, Ahrens C, Lohrs U. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma. Virchows Arch 2000;436:102-8.
4. van Engeland M, Nieland L, Ramaekers F, Schutte B, Reutelingsperger C. Annexin-V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998;31:1-9.
5. Narula J, Acio ER, Narula N, Samuels L, Fyfe B, Wood D, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nature Med 2001;7:1347-52.
6. Hofstra L, Liem I, Dumont EA, Boersma H, van Heerde W, Doevendans P, et al. Visualization of cell death in vivo in patients with acute myocardial infarction. Lancet 2000;356:209-12.
7. Blankenberg F, Vriens P, Tait J. Non-invasive detection and quantification of acute heart transplant rejection using 99mTc radiolabeled annexin V. Radiology 1998;103 (abstr 1337).
8. Narula J, Acia E, Narula N. Phase-I Tc99m-Annexin-V imaging study in heart transplant rejection: can noninvasive detection of apoptosis in cardiac allografts obviate the need for endomyocardial biopsy. Circulation 2000;102 (abstr 3714).
9. Van de Wiele C, Lahorte C, Vermeersch H, Loose D, Mervillie K, Steinmetz N, et al. Quantitative tumor apoptosis imaging using 99mTc-HYNIC Annexin single photon emission computerized tomography. J Clin Oncol 2003;21:3483-7.
10. Vermeersch H, Ham H, Rottey S, Lahorte C, Corsetti F, Dierckx R, et al. Intra-observer, inter-observer and day-to-day reproducibility of quantitative 99mTc-HYNIC Annexin V imaging in head and neck carcinoma. Cancer Biother Radiopharm 2004;2:205-10.
11. Rottey S, Slegers G, Van Belle S, Goethals I, Van de Wiele C. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med 2006;47:1813-8.
12. Hall P. Assessing apoptosis: a critical survey. Endocr-Relat Cancer 1999;6:3-8.
13. Mundle S, Gao X, Khan S, Gregory S, Preisler H, Razza A. Two in situ end labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo and induced apoptosis in vitro. Anticancer Res 1995;15:1895-904.
14. Hotz M, Bosq J, Zbaeren P, Reed J, Schwab G, Krajewski S, et al. Spontaneous apoptosis and the expression of p53 and Bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:417-22.
15. Naresh K, Lakshminarayanan K, Pai S, Borges A. Apoptosis index is a predictor of metastatic phenotype in patients with early stage squamous carcinoma of the tongue. Cancer 2001;91:578-84.
16. Xie X, De Angelis P, Clausen O, Boysen M. Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol 1999;35:502-9.
17. Hirvikoski P, Virtaniemi J, Kumpulainen E, Johansson R, Kosma V. Supraglottic and glottic carcinomas: clinically and biologically distinct entities. Eur J Cancer 2002;38:1717-23.
18. Teppo H, Soini Y, Melkko J, Koivunen P, Alho P. Prognostic factors in laryngeal carcinoma: the role of apoptosis, p53, proliferation (Ki-67) and angiogenesis. APMIS 2003;111:451-7.
19. Jäckel M, Dorudian M, Marx D, Brinck U, Schauer A, Steiner W. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 1999;85:591-9.
20. Gastman B. Apoptosis and its clinical impact. Head Neck 2001;23:409-25.
21. Gastman B, Atarshi Y, Reichert T, Saito T, Balkir L, Rabinowich H, et al. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res 1991;59:5356-64.